Distal Femoral Osteoarticular Allografts: Long-term Survival, But Frequent Complications
Distal Femoral Osteoarticular Allografts: Long-term Survival, But Frequent Complications
复制标题
股骨远端同种异体骨关节移植:生存期长,但并发症频繁
DOI:
--
复制
发表时间:
2010
影响因子:
4.2
通讯作者:
Parker C. Gibbs
中科院分区:
文献类型:
--
作者:
Patrick C. Toy;Jeremy R. White;M. Scarborough;W. Enneking;Parker C. Gibbs
BackgroundComplications are frequent with osteoarticular allografts, and their long-term survivorship in the distal femur is unclear. Thus, the benefits of osteoarticular allografting remain controversial.Questions/purposesWe therefore determined the frequency of complications in osteoarticular allografts of the distal femur relative to their potential long-term survival.MethodsWe retrospectively reviewed 26 patients who had osteoarticular allograft reconstruction of the distal femur after resection of a malignant or aggressive benign tumor of bone. The minimum followup was 15 months (average, 156 months; range, 15–283 months) for all patients and 98 months (average, 191 months; range, 98–283 months) for the surviving patients.ResultsAt last followup, 16 of the 26 original allografts were still in place. The overall 5-year and 10-year allograft survival rates were 69% and 63%, respectively. The 5-year and 10-year survival rates of the joint surface were 79% and 65%, respectively. Eleven patients retained their original osteoarticular allograft without a resurfacing procedure, and nine had been converted to allograft-prosthetic composites. Five patients were converted to megaprostheses and one had an amputation for local recurrence. At last followup, 25 of 26 patients retained a functional limb.ConclusionsOsteoarticular allograft reconstructions of the distal femur can provide long term survival and restore function but the risk of complications and their physical and monetary costs for patients are not trivial. Lacking the benefit of improved soft tissue attachments inherent in other anatomic sites, we believe this option is most appropriate for restoring bone stock in young patients with expectations of long-term survival.Level of EvidenceLevel IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
DOI:
--
发表时间:
1987
期刊:
The Orthopedic clinics of North America
影响因子:
--
作者:
Mankin,HJ;Gebhardt,MC;Tomford,WW
通讯作者:
Tomford,WW
DOI:
10.2106/00004623-199311000-00011
发表时间:
1993-11-01
影响因子:
5.3
作者:
THOMPSON, RC;PICKVANCE, EA;GARRY, D
通讯作者:
GARRY, D